Meeting Abstracts

PROSTest Abstracts

ASCO Genitourinary Cancers Symposium – February 2020

• Rahbar, K., M. Kidd, Drozdov I, Kitz A, Malczewska A, Rajwa P, Boegemann M, Bernemann C, Bodei L, and I. M. Modlin. “A blood-based multi mRNA liquid biopsy with >90% accuracy for diagnosis and assessment of prostate cancers.” Journal of Clinical Oncology 2020; 38(Suppl 15): A5574.
• American Association for Cancer Research 2020
• Rahbar K, Kidd M, Drozdov I, Kitz A, Malczewska A, Rajwa P, Bernemann C, Bodei L, and I. M. Modlin. A multi-gene prostate cancer liquid biopsy with > 92% accuracy in diagnosis and assessment of disease status. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 3389.

ASCO Genitourinary Cancers Symposium – February 2023

• Chirindel, A., M. Kidd, C. Rentsch, F. Stenner, A. Templeton, E. U. Nitzsche, D. Wild, G. Nicolas and I. Modlin. “Evaluation of a novel transcriptomic tumor signature (PROSTest) as response biomarker for 177Lu-PSMA therapy in advanced prostate cancer.” Journal of Clinical Oncology 2023; 41(6 Suppl): A183.
• Modlin I. M., M. Kidd, Drozdov I, Boegemann M, Bodei L, Kunikowska J, Malczewska A, Bernemann C, Rahbar K. “Development and validation of a multigenomic liquid biopsy (PROSTest) for prostate cancer detection.” Journal of Clinical Oncology 2023; 41(Suppl 6): A252.
• Rahbar, K., M. Kidd, K. Seitzer, A. J. Schrader, M. Boegemann and I. M. Modlin. “Prediction of early prostate cancer recurrence using a liquid biopsy approach.” Journal of Clinical Oncology 2023; 41(Suppl 6): A386.